Lung Adenocarcinoma with Mucinous Histology By Ogkologos - December 16, 2024 959 0 Facebook Twitter Google+ Pinterest WhatsApp Clinicopathologic, genomic, immunophenotypic, transcriptional features, and treatment outcomes Source RELATED ARTICLESMORE FROM AUTHOR ESMO Announces 2026 Society Award Recipients Honouring Excellence in Cancer Research, Care and Leadership Adjuvant Olaparib Continues to Improve Multiple Outcomes in Patients with Germline BRCA1/2-associated High-Risk HER2-negative EBC EMA Recommends Refusing the Marketing Authorisation for Copper (64Cu) Oxodotreotide MOST POPULAR Could Functional Precision Medicine Be the New Precision Oncology? August 6, 2026 Adding Atezolizumab to Cabozantinib Fails to Improve Clinical Outcomes and Increases... June 13, 2023 EMA Recommends Granting Marketing Authorisation for Generic Abiraterone Acetate May 4, 2021 Oncogenic Drivers Associated with Late Recurrence in Postmenopausal Women with ER-positive/HER2-negative... July 10, 2020 Load more HOT NEWS How Alcohol Increases Your Cancer Risk and What to Know About... We want every scientist to thrive in cancer research FDA Grants Regular Approval to Enfortumab Vedotin-ejfv for Locally Advanced or... Quizartinib Approval Adds New Treatment Option for AML, Including in Older...
